Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Environmental Science and Pollution Research International
|
December 14, 2017
Catalytic degradation of sulfaquinoxalinum by polyester/poly-4-vinylpyridine nanofibers-supported iron phthalocyanine
Nan Li, Panting Lu, Cuixia He, et al.
Frontiers in Pharmacology
|
October 24, 2022
The regulatory role of PDE4B in the progression of inflammatory function study
Yue Su, Jiaxiang Ding, Fan Yang, et al.
Frontiers in Pharmacology
|
November 7, 2022
Research progress on microRNA in gout
Jing Xie, Cuixia He, Yue Su, et al.
Investigational New Drugs
|
May 2, 2023
Drug-drug interaction potential of SH-1028, a third-generation EGFR-TKI: in vitro and clinical trials
Xiaoli Li, Yuyan Liu, Minhui Zhu, et al.
BMC Pharmacology & Toxicology
|
May 27, 2023
A phase I study comparing the biosimilarity of the pharmacokinetics and safety of recombinant humanized anti-vascular endothelial growth factor monoclonal antibody injection with Avastin<sup>®</sup> in healthy Chinese male subjects
Hongtao Li, Xiangdi Zhao, Jing Xie, et al.
Frontiers in Pharmacology
|
January 21, 2022
TMEM88 Modulates Lipid Synthesis and Metabolism Cytokine by Regulating Wnt/β-Catenin Signaling Pathway in Non-Alcoholic Fatty Liver Disease
Huan Zhou, Xingyu Zhu, Yan Yao, et al.
BMC Pharmacology & Toxicology
|
February 22, 2023
Oseltamivir phosphate for suspension is bioequivalent to TAMIFLU in healthy volunteers: a randomized, open-label clinical study
Ying Wang, Bangzhong Tang, Jing Xie, et al.
Clinical Pharmacology in Drug Development
|
July 18, 2022
Pharmacokinetic Characteristics, Safety, and Tolerability of Telitacicept, an Injectable Recombinant Human B-Lymphocyte Stimulating Factor Receptor-Antibody Fusion Protein, in Healthy Chinese Subjects
Jing Xie, Xiaoyun Fan, Yue Su, et al.
Cancer Chemotherapy and Pharmacology
|
December 26, 2022
Mass balance, metabolic disposition, and pharmacokinetics of a novel selective inhibitor of PI3Kδ [<sup>14</sup>C] SHC014748M in healthy Chinese subjects following oral administration
Fei Guo, Bingyan Liu, Xiaoli Li, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
August 10, 2021
Pharmacokinetic and pharmacodynamic evaluation of the new prolonged-release leuprorelin acetate microspheres for injection compared with Enantone® in healthy Chinese male volunteers
Huan Zhou, Jing Xie, Xingyu Zhu, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Environmental Science and Pollution Research International
|
December 14, 2017
Catalytic degradation of sulfaquinoxalinum by polyester/poly-4-vinylpyridine nanofibers-supported iron phthalocyanine
Nan Li, Panting Lu, Cuixia He, et al.
Frontiers in Pharmacology
|
October 24, 2022
The regulatory role of PDE4B in the progression of inflammatory function study
Yue Su, Jiaxiang Ding, Fan Yang, et al.
Frontiers in Pharmacology
|
November 7, 2022
Research progress on microRNA in gout
Jing Xie, Cuixia He, Yue Su, et al.
Investigational New Drugs
|
May 2, 2023
Drug-drug interaction potential of SH-1028, a third-generation EGFR-TKI: in vitro and clinical trials
Xiaoli Li, Yuyan Liu, Minhui Zhu, et al.
BMC Pharmacology & Toxicology
|
May 27, 2023
A phase I study comparing the biosimilarity of the pharmacokinetics and safety of recombinant humanized anti-vascular endothelial growth factor monoclonal antibody injection with Avastin<sup>®</sup> in healthy Chinese male subjects
Hongtao Li, Xiangdi Zhao, Jing Xie, et al.
Frontiers in Pharmacology
|
January 21, 2022
TMEM88 Modulates Lipid Synthesis and Metabolism Cytokine by Regulating Wnt/β-Catenin Signaling Pathway in Non-Alcoholic Fatty Liver Disease
Huan Zhou, Xingyu Zhu, Yan Yao, et al.
BMC Pharmacology & Toxicology
|
February 22, 2023
Oseltamivir phosphate for suspension is bioequivalent to TAMIFLU in healthy volunteers: a randomized, open-label clinical study
Ying Wang, Bangzhong Tang, Jing Xie, et al.
Clinical Pharmacology in Drug Development
|
July 18, 2022
Pharmacokinetic Characteristics, Safety, and Tolerability of Telitacicept, an Injectable Recombinant Human B-Lymphocyte Stimulating Factor Receptor-Antibody Fusion Protein, in Healthy Chinese Subjects
Jing Xie, Xiaoyun Fan, Yue Su, et al.
Cancer Chemotherapy and Pharmacology
|
December 26, 2022
Mass balance, metabolic disposition, and pharmacokinetics of a novel selective inhibitor of PI3Kδ [<sup>14</sup>C] SHC014748M in healthy Chinese subjects following oral administration
Fei Guo, Bingyan Liu, Xiaoli Li, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
August 10, 2021
Pharmacokinetic and pharmacodynamic evaluation of the new prolonged-release leuprorelin acetate microspheres for injection compared with Enantone® in healthy Chinese male volunteers
Huan Zhou, Jing Xie, Xingyu Zhu, et al.
Page
of 1